racemetirosine has been researched along with Acute Confusional Senile Dementia in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, P | 1 |
| Alafuzoff, I | 1 |
| Carlsson, A | 1 |
| Eriksson, K | 1 |
| Ericson, E | 1 |
| Gottfries, CG | 1 |
| Marcusson, JO | 1 |
1 other study available for racemetirosine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.
Topics: Aged; alpha-Methyltyrosine; Alzheimer Disease; Dopamine; Female; Homovanillic Acid; Humans; In Vitro | 1990 |